Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.

Alashek WA, McIntyre CW, Taal MW.

BMC Infect Dis. 2012 Oct 20;12:265. doi: 10.1186/1471-2334-12-265.

PMID:
23082935
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Determinants of survival in patients receiving dialysis in Libya.

Alashek WA, McIntyre CW, Taal MW.

Hemodial Int. 2013 Apr;17(2):249-55. doi: 10.1111/j.1542-4758.2012.00728.x. Epub 2012 Aug 13.

PMID:
22882674
[PubMed - indexed for MEDLINE]
3.

Vascular access in patients receiving hemodialysis in Libya.

Alashek WA, McIntyre CW, Taal MW.

J Vasc Access. 2012 Oct-Dec;13(4):468-74. doi: 10.5301/jva.5000089.

PMID:
22865528
[PubMed - in process]
4.

Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya.

Alashek WA, McIntyre CW, Taal MW.

BMC Nephrol. 2012 Jun 8;13:33. doi: 10.1186/1471-2369-13-33.

PMID:
22682181
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Provision and quality of dialysis services in Libya.

Alashek WA, McIntyre CW, Taal MW.

Hemodial Int. 2011 Oct;15(4):444-52. doi: 10.1111/j.1542-4758.2011.00588.x. Epub 2011 Aug 18.

PMID:
22111812
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk